Xenetic Biosciences is trading at $2.16, up 8.18%, amid a broadly higher market; no company-specific announcement or catalyst for November 2 was identified.

  • The latest company news found was an October 15 clinical-study update.
  • The S&P 500 is up 0.55%, the Nasdaq 0.79%, and the Dow 1.06%.
  • Recent trading has been volatile, including a 15.09% gain on October 28; no volume data was provided.